UBS Group’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,946
| Closed | -$9K | – | 8650 |
|
|
2020
Q4 | $9K | Sell |
2,946
-526
| -15% | -$1.61K | ﹤0.01% | 6571 |
|
|
2020
Q3 | $11K | Buy |
+3,472
| New | +$11K | ﹤0.01% | 5947 |
|
|
2020
Q2 | – | Sell |
-1,390
| Closed | -$7K | – | 7656 |
|
|
2020
Q1 | $7K | Sell |
1,390
-437
| -24% | -$2.2K | ﹤0.01% | 6278 |
|
|
2019
Q4 | $91K | Buy |
+1,827
| New | +$91K | ﹤0.01% | 5024 |
|
|
2019
Q3 | – | Sell |
-100
| Closed | -$1K | – | 7345 |
|
|
2019
Q2 | $1K | Sell |
100
-618
| -86% | -$6.18K | ﹤0.01% | 6915 |
|
|
2019
Q1 | $6K | Buy |
718
+23
| +3% | +$192 | ﹤0.01% | 6289 |
|
|
2018
Q4 | $6K | Buy |
+695
| New | +$6K | ﹤0.01% | 6585 |
|
|
2018
Q3 | – | Sell |
-721
| Closed | -$6K | – | 7321 |
|
|
2018
Q2 | $6K | Buy |
+721
| New | +$6K | ﹤0.01% | 6508 |
|
|
2017
Q3 | – | Sell |
-867
| Closed | -$8K | – | 7018 |
|
|
2017
Q2 | $8K | Buy |
867
+746
| +617% | +$6.88K | ﹤0.01% | 5997 |
|
|
2017
Q1 | $3K | Sell |
121
-48
| -28% | -$1.19K | ﹤0.01% | 6299 |
|
|
2016
Q4 | $7K | Buy |
+169
| New | +$7K | ﹤0.01% | 6146 |
|
|
2016
Q3 | – | Sell |
-6
| Closed | – | – | 6973 |
|
|
2016
Q2 | $0 | Sell |
6
-24
| -80% | – | ﹤0.01% | 7024 |
|
|
2016
Q1 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 6608 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | – | – | 7092 |
|
|
2015
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 7039 |
|
|
2015
Q2 | – | Sell |
-36
| Closed | -$5K | – | 6972 |
|
|
2015
Q1 | $5K | Buy |
+36
| New | +$5K | ﹤0.01% | 6204 |
|